Astellas to Acquire Ocata Therapeutics
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/10/2026
- Wall Street posts weekly gains with earnings, inflation data on tap
- Oil prices settle higher as more production shut ahead of hurricane
- Apple cuts iPhone 18 Pro orders due to soft demand, Nikkei Asia reports
- UBS flags level in gold prices where dip buyers will likely emerge
- Telecom stocks tumble on SpaceX spectrum acquisition news
| Astellas Pharma Inc Unsponsored ADR (AMEX: ALPMY) | Delayed: 14.35 +0.15 (1.06%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $14.20 | 52 Week High | $19.40 | |||
| Open | $14.17 | 52 Week Low | $12.50 | |||
| Day High | $14.37 | P/E | N/A | |||
| Day Low | $14.17 | EPS | $0.00 | |||
| Volume | 122,213 | |||||
| (NASDAQ: OCAT) | Delayed: 8.47 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $8.47 | 52 Week High | $8.71 | |||
| Open | $11.52 | 52 Week Low | $3.06 | |||
| Day High | $8.47 | P/E | N/A | |||
| Day Low | $8.47 | EPS | $0.00 | |||
| Volume | 9,796 | |||||
